These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11285883)

  • 41. [Which is the better choice, estrogen or SERMs in postmenopausal women?].
    Shintani M
    Clin Calcium; 2004 Oct; 14(10):105-10. PubMed ID: 15577140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Osteoporosis guidelines.
    Laupacis A
    CMAJ; 2003 Jun; 168(13):1644-5; author reply 1645-6. PubMed ID: 12821610
    [No Abstract]   [Full Text] [Related]  

  • 43. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
    Yosipovitch G; Hoon TS; Leok GC
    Arch Dermatol; 2001 Apr; 137(4):477-81. PubMed ID: 11295929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The treatment of established osteoporosis].
    Lamy O; Burckhardt P; Thiébaud D
    Rev Med Suisse Romande; 1995 Feb; 115(2):121-6. PubMed ID: 7886366
    [No Abstract]   [Full Text] [Related]  

  • 45. Raloxifene reduces risk of vertebral fractures [corrected] in postmenopausal women regardless of prior hormone therapy.
    Johnell O; Cauley JA; Kulkarni PM; Wong M; Stock JL
    J Fam Pract; 2004 Oct; 53(10):789-96. PubMed ID: 15469774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [SERM for early osteoporosis therapy. Risk for first spinal fracture reduced to half].
    MMW Fortschr Med; 2003 May; 145(22):57. PubMed ID: 12866287
    [No Abstract]   [Full Text] [Related]  

  • 47. Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial.
    Lufkin EG; Sarkar S; Kulkarni PM; Ciaccia AV; Siddhanti S; Stock J; Plouffe L
    Curr Med Res Opin; 2004 Mar; 20(3):351-7. PubMed ID: 15025844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Oral osteoporosis: a review and its dental implications].
    Inagaki K; Kurosu Y; Sakano M; Yamamoto G; Kikuchi T; Noguchi T; Yano H; Izawa H; Hachiya Y
    Clin Calcium; 2007 Feb; 17(2):157-63. PubMed ID: 17272871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Not all SERMs are created equal.
    Goldstein SR
    Menopause; 2006; 13(3):325-7. PubMed ID: 16735926
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacologic prevention and treatment of osteoporosis in women.
    Capriotti T
    Medsurg Nurs; 2000 Apr; 9(2):86-90. PubMed ID: 11033696
    [No Abstract]   [Full Text] [Related]  

  • 51. Osteoporosis: evaluation and treatment.
    Bajaj S; Saag KG
    Curr Womens Health Rep; 2003 Oct; 3(5):418-24. PubMed ID: 12959702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of estrogen and selective estrogen receptor modulators on osteoporosis].
    Urano T
    Clin Calcium; 2005 Apr; 15(4):591-5. PubMed ID: 15802770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biological basis of anti-resorptive therapies for osteoporosis.
    Zaidi M
    Aging (Milano); 1998 Apr; 10(2):157-8. PubMed ID: 9666212
    [No Abstract]   [Full Text] [Related]  

  • 54. Diagnosing and managing post menopausal osteoporosis: opportunities for fracture prevention.
    McGarry KA; Tammaro D; Cyr MG
    Compr Ther; 2003; 29(2-3):115-23. PubMed ID: 14606341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Raloxifene: a new choice for treating and preventing osteoporosis.
    Licata AA; Ciaccia AV; Wong M; Draper MW
    Cleve Clin J Med; 2000 Apr; 67(4):273-80. PubMed ID: 10780099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of osteoporosis: current status and recent advances.
    Theodorou DJ; Theodorou SJ; Sartoris DJ
    Compr Ther; 2002; 28(2):109-22. PubMed ID: 12085458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency of bone densitometry for osteoporosis?
    Kleerekoper M
    Postgrad Med; 1999 Nov; 106(6):22. PubMed ID: 10575998
    [No Abstract]   [Full Text] [Related]  

  • 58. Focus on primary care postmenopausal osteoporosis: an update.
    Watts NB
    Obstet Gynecol Surv; 2000 Dec; 55(12 Suppl 3):S49-55. PubMed ID: 11128912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lasofoxifene for postmenopausal women with osteoporosis.
    Malozowski S
    N Engl J Med; 2010 Jun; 362(23):2227; author reply 2228-9. PubMed ID: 20558377
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacotherapy of osteoporosis in postmenopausal women: focus on safety.
    Reid IR
    Expert Opin Drug Saf; 2002 May; 1(1):93-107. PubMed ID: 12904164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.